UCLA's cancer 'roadmap' could help combat resistance to targeted drug therapies

(PhysOrg.com) -- New drugs that specifically target the mutated genes responsible for cancer growth have shown great success in extending the lives of patients, with far fewer side effects than conventional anti-cancer therapies. Unfortunately, many patients become resistant to these drugs due to secondary mutations.

Read the whole article on Physorg

More from Physorg